T1	Participants 82 109	hematologic cancer patients
T2	Participants 383 410	hematologic cancer patients
T3	Participants 576 603	hematologic cancer patients
T4	Participants 612 646	One hundred eighty-six registrants
T5	Participants 1138 1210	One hundred eleven patients filled out the post questionnaire at 4 weeks
T6	Participants 612 694	One hundred eighty-six registrants were randomly assigned to an intervention group
T7	Participants 1481 1527	Patient satisfaction with the program was high
